{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:41:50Z","timestamp":1787002910373,"version":"build-2736575974"},"reference-count":105,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T00:00:00Z","timestamp":1774310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T00:00:00Z","timestamp":1774310400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Psychiatry"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1038\/s41380-026-03538-y","type":"journal-article","created":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T13:33:21Z","timestamp":1774359201000},"page":"4297-4309","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Anesthetics as emerging therapeutics for post-traumatic stress disorder (PTSD): bridging bench and bedside"],"prefix":"10.1038","volume":"31","author":[{"given":"Xinchun","family":"Mei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8437-3194","authenticated-orcid":false,"given":"Haitao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0510-715X","authenticated-orcid":false,"given":"Tifei","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James N.","family":"Samsom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siqi","family":"Ying","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1438-0038","authenticated-orcid":false,"given":"Tianle","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5414-4160","authenticated-orcid":false,"given":"Fang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7811-1478","authenticated-orcid":false,"given":"Yuan","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,24]]},"reference":[{"key":"3538_CR1","doi-asserted-by":"publisher","first-page":"502","DOI":"10.2174\/1874467214666210525160944","volume":"15","author":"A Thakur","year":"2022","unstructured":"Thakur A, Choudhary D, Kumar B, Chaudhary A. A review on post-traumatic stress disorder (PTSD): symptoms, therapies and recent case studies. Curr Mol Pharmacol. 2022;15:502\u201316.","journal-title":"Curr Mol Pharmacol"},{"key":"3538_CR2","doi-asserted-by":"publisher","first-page":"870","DOI":"10.30773\/pi.2024.0147","volume":"21","author":"S Chang","year":"2024","unstructured":"Chang S, Kim WH, Jung YE, Roh D, Kim D, Chae JH, et al. Clinical utility of impact of event scale-revised for diagnostic and statistical manual of mental disorders-fifth edition posttraumatic stress disorder. Psychiatry Investig. 2024;21:870\u20136.","journal-title":"Psychiatry Investig"},{"key":"3538_CR3","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/s41582-022-00635-8","volume":"18","author":"KJ Ressler","year":"2022","unstructured":"Ressler KJ, Berretta S, Bolshakov VY, Rosso IM, Meloni EG, Rauch SL, et al. Post-traumatic stress disorder: clinical and translational neuroscience from cells to circuits. Nat Rev Neurol. 2022;18:273\u201388.","journal-title":"Nat Rev Neurol"},{"key":"3538_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cpr.2017.09.001","volume":"58","author":"CR Brewin","year":"2017","unstructured":"Brewin CR, Cloitre M, Hyland P, Shevlin M, Maercker A, Bryant RA, et al. A review of current evidence regarding the ICD-11 proposals for diagnosing PTSD and complex PTSD. Clin Psychol Rev. 2017;58:1\u201315.","journal-title":"Clin Psychol Rev"},{"key":"3538_CR5","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.janxdis.2010.11.010","volume":"25","author":"RH Pietrzak","year":"2011","unstructured":"Pietrzak RH, Goldstein RB, Southwick SM, Grant BF. Prevalence and axis I comorbidity of full and partial posttraumatic stress disorder in the United States: results from Wave 2 of the national epidemiologic survey on alcohol and related conditions. J Anxiety Disord. 2011;25:456\u201365.","journal-title":"J Anxiety Disord"},{"key":"3538_CR6","first-page":"4","volume":"61","author":"RC Kessler","year":"2000","unstructured":"Kessler RC. Posttraumatic stress disorder: the burden to the individual and to society. J Clin Psychiat. 2000;61:4\u201314.","journal-title":"J Clin Psychiat"},{"key":"3538_CR7","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1038\/s41583-018-0039-7","volume":"19","author":"RJ Fenster","year":"2018","unstructured":"Fenster RJ, Lebois LAM, Ressler KJ, Suh J. Brain circuit dysfunction in post-traumatic stress disorder: from mouse to man. Nat Rev Neurosci. 2018;19:535\u201351.","journal-title":"Nat Rev Neurosci"},{"key":"3538_CR8","doi-asserted-by":"publisher","first-page":"1281401","DOI":"10.3389\/fnins.2023.1281401","volume":"17","author":"J Iqbal","year":"2023","unstructured":"Iqbal J, Huang GD, Xue YX, Yang M, Jia XJ. The neural circuits and molecular mechanisms underlying fear dysregulation in posttraumatic stress disorder. Front Neurosci. 2023;17:1281401.","journal-title":"Front Neurosci"},{"key":"3538_CR9","doi-asserted-by":"publisher","first-page":"e51","DOI":"10.1016\/j.biopsych.2017.03.007","volume":"82","author":"JH Krystal","year":"2017","unstructured":"Krystal JH, Davis LL, Neylan TC, A Raskind M, Schnurr PP, Stein MB, et al. It is time to address the crisis in the pharmacotherapy of posttraumatic stress disorder: a consensus statement of the PTSD psychopharmacology working group. Biol Psychiatry. 2017;82:e51\u2013e59.","journal-title":"Biol Psychiatry"},{"key":"3538_CR10","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1038\/nrn3339","volume":"13","author":"RK Pitman","year":"2012","unstructured":"Pitman RK, Rasmusson AM, Koenen KC, Shin LM, Orr SP, Gilbertson MW, et al. Biological studies of post-traumatic stress disorder. Nat Rev Neurosci. 2012;13:769\u201387.","journal-title":"Nat Rev Neurosci"},{"key":"3538_CR11","first-page":"1731","volume":"13","author":"D Marazziti","year":"2023","unstructured":"Marazziti D, Carmassi C, Cappellato G, Chiarantini I, Massoni L, Mucci F, et al. Novel pharmacological targets of post-traumatic stress disorders. Life (Basel). 2023;13:1731.","journal-title":"Life (Basel)"},{"key":"3538_CR12","doi-asserted-by":"publisher","first-page":"107551","DOI":"10.1016\/j.pharmthera.2020.107551","volume":"211","author":"B Sbarski","year":"2020","unstructured":"Sbarski B, Akirav I. Cannabinoids as therapeutics for PTSD. Pharmacol Ther. 2020;211:107551.","journal-title":"Pharmacol Ther"},{"key":"3538_CR13","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.neubiorev.2016.08.023","volume":"71","author":"MBL Careaga","year":"2016","unstructured":"Careaga MBL, Girardi CEN, Suchecki D. Understanding posttraumatic stress disorder through fear conditioning, extinction and reconsolidation. Neurosci Biobehav Rev. 2016;71:48\u201357.","journal-title":"Neurosci Biobehav Rev"},{"key":"3538_CR14","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1016\/j.biopsych.2006.06.032","volume":"61","author":"MA Raskind","year":"2007","unstructured":"Raskind MA, Peskind ER, Hoff DJ, Hart KL, Holmes HA, Warren D, et al. A parallel group placebo controlled study of prazosin for trauma nightmares and sleep disturbance in combat veterans with post-traumatic stress disorder. Biol Psychiatry. 2007;61:928\u201334.","journal-title":"Biol Psychiatry"},{"key":"3538_CR15","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1176\/ajp.152.7.973","volume":"152","author":"JD Bremner","year":"1995","unstructured":"Bremner JD, Randall P, Scott TM, Bronen RA, Seibyl JP, Southwick SM, et al. MRI-based measurement of hippocampal volume in patients with combat-related posttraumatic stress disorder. Am J Psychiatry. 1995;152:973\u201381.","journal-title":"Am J Psychiatry"},{"key":"3538_CR16","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1001\/archgenpsychiatry.2012.73","volume":"69","author":"JR Kuo","year":"2012","unstructured":"Kuo JR, Kaloupek DG, Woodward SH. Amygdala volume in combat-exposed veterans with and without posttraumatic stress disorder: a cross-sectional study. Arch Gen Psychiatry. 2012;69:1080\u20136.","journal-title":"Arch Gen Psychiatry"},{"key":"3538_CR17","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.jpsychires.2005.12.002","volume":"41","author":"R Yehuda","year":"2007","unstructured":"Yehuda R, Golier JA, Tischler L, Harvey PD, Newmark R, Yang RK, et al. Hippocampal volume in aging combat veterans with and without post-traumatic stress disorder: relation to risk and resilience factors. J Psychiatr Res. 2007;41:435\u201345.","journal-title":"J Psychiatr Res"},{"key":"3538_CR18","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/bs.pbr.2025.01.009","volume":"291","author":"L Agbaria","year":"2025","unstructured":"Agbaria L, Mirzaei F, A\u2019Amar NO, Raba FT, Papazian G, Bhatnagar K, et al. The neuroscientific basis of post-traumatic stress disorder (PTSD): From brain to treatment. Prog Brain Res. 2025;291:427\u201368.","journal-title":"Prog Brain Res"},{"key":"3538_CR19","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1176\/appi.ajp.162.2.214","volume":"162","author":"R Bradley","year":"2005","unstructured":"Bradley R, Greene J, Russ E, Dutra L, Westen D. A multidimensional meta-analysis of psychotherapy for PTSD. Am J Psychiat. 2005;162:214\u201327.","journal-title":"Am J Psychiat"},{"key":"3538_CR20","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1521\/psyc.2008.71.2.134","volume":"71","author":"MA Schottenbauer","year":"2008","unstructured":"Schottenbauer MA, Glass CR, Arnkoff DB, Tendick V, Gray SH. Nonresponse and dropout rates in outcome studies on PTSD: Review and methodological considerations. Psychiatry. 2008;71:134\u201368.","journal-title":"Psychiatry"},{"key":"3538_CR21","first-page":"CD002795","volume":"3","author":"T Williams","year":"2022","unstructured":"Williams T, Phillips NJ, Stein DJ, Ipser JC. Pharmacotherapy for post traumatic stress disorder (PTSD). Cochrane Database Syst Rev. 2022;3:CD002795.","journal-title":"Cochrane Database Syst Rev"},{"key":"3538_CR22","unstructured":"American Psychological Association, Guideline Development Panel for the Treatment of PTSD in Adults. Clinical practice guideline for the treatment of Posttraumatic Stress Disorder (PTSD) in adults. 2017. Retrieved from http:\/\/www.apa.org\/about\/offices\/directorates\/guidelines\/ptsd.pdf."},{"key":"3538_CR23","first-page":"CD012898","volume":"2019","author":"BE Belsher","year":"2019","unstructured":"Belsher BE, Beech E, Evatt D, Smolenski DJ, Shea MT, Otto JL, et al. Present-centered therapy (PCT) for post-traumatic stress disorder (PTSD) in adults. Cochrane Database Syst Rev. 2019;2019:CD012898.","journal-title":"Cochrane Database Syst Rev"},{"key":"3538_CR24","unstructured":"Post-traumatic stress disorder. London: National Institute for Health and Care Excellence (NICE); 2018. National Institute for Health and Care Excellence: Guidelines."},{"key":"3538_CR25","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1002\/jts.22774","volume":"35","author":"DC Rozek","year":"2022","unstructured":"Rozek DC, Baker SN, Rugo KF, Steigerwald VL, Sippel LM, Holliday R, et al. Addressing co-occurring suicidal thoughts and behaviors and posttraumatic stress disorder in evidence-based psychotherapies for adults: A systematic review. J Trauma Stress. 2022;35:729\u201345.","journal-title":"J Trauma Stress"},{"key":"3538_CR26","doi-asserted-by":"crossref","unstructured":"Lofthouse K, Davies A, Hodgekins J, Meiser-Stedman R. Systematic review and meta-analysis: imputing response rates for first-line psychological treatments for posttraumatic stress disorder in youth. J Am Acad Child Adolesc Psychiatry.\u00a02026;65:187\u2013205.","DOI":"10.1016\/j.jaac.2024.12.014"},{"key":"3538_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/s12888-024-05656-9","volume":"24","author":"JR Klaeth","year":"2024","unstructured":"Klaeth JR, Jensen AG, Auren TJB, Solem S. 12-month follow-up of intensive outpatient treatment for PTSD combining prolonged exposure therapy, EMDR and physical activity. BMC Psychiatry. 2024;24:225.","journal-title":"BMC Psychiatry"},{"key":"3538_CR28","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.pnpbp.2008.12.004","volume":"33","author":"W Berger","year":"2009","unstructured":"Berger W, Mendlowicz MV, Marques-Portella C, Kinrys G, Fontenelle LF, Marmar CR, et al. Pharmacologic alternatives to antidepressants in posttraumatic stress disorder: A systematic review. Prog Neuro-Psychoph. 2009;33:169\u201380.","journal-title":"Prog Neuro-Psychoph"},{"key":"3538_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2019.112637","volume":"282","author":"J Sonis","year":"2019","unstructured":"Sonis J, Cook JM. Medication versus trauma-focused psychotherapy for adults with posttraumatic stress disorder: A systematic review and meta-analysis. Psychiatry Res. 2019;282:112637.","journal-title":"Psychiatry Res"},{"key":"3538_CR30","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.pnpbp.2018.05.006","volume":"88","author":"JRM Goodnight","year":"2019","unstructured":"Goodnight JRM, Ragsdale KA, Rauch SAM, Rothbaum BO. Psychotherapy for PTSD: An evidence-based guide to a theranostic approach to treatment. Prog Neuropsychopharmacol Biol Psychiatry. 2019;88:418\u201326.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"3538_CR31","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1682\/JRRD.2011.09.0183","volume":"49","author":"M Jeffreys","year":"2012","unstructured":"Jeffreys M, Capehart B, Friedman MJ. Pharmacotherapy for posttraumatic stress disorder: Review with clinical applications. J Rehabil Res Dev. 2012;49:703\u201315.","journal-title":"J Rehabil Res Dev"},{"key":"3538_CR32","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1002\/da.22384","volume":"32","author":"FR Schneier","year":"2015","unstructured":"Schneier FR, Campeas R, Carcamo J, Glass A, Lewis-Fernandez R, Neria Y, et al. Combined Mirtazapine and Ssri Treatment of Ptsd: A Placebo-Controlled Trial. Depress Anxiety. 2015;32:570\u20139.","journal-title":"Depress Anxiety"},{"key":"3538_CR33","volume-title":"Committee on Treatment of Posttraumatic Stress Disorder. Treatment of posttraumatic stress disorder : an assessment of the evidence.","author":"Institute of Medicine (U.S.)","year":"2008","unstructured":"Institute of Medicine (U.S.). Committee on Treatment of Posttraumatic Stress Disorder. Treatment of posttraumatic stress disorder : an assessment of the evidence. Washington, D.C.: National Academies Press; 2008. xii, 212 p.pp"},{"key":"3538_CR34","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1126\/science.1149213","volume":"322","author":"MT Alkire","year":"2008","unstructured":"Alkire MT, Hudetz AG, Tononi G. Consciousness and anesthesia. Science. 2008;322:876\u201380.","journal-title":"Science"},{"key":"3538_CR35","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1001\/jamapsychiatry.2014.62","volume":"71","author":"A Feder","year":"2014","unstructured":"Feder A, Parides MK, Murrough JW, Perez AM, Morgan JE, Saxena S, et al. Efficacy of intravenous ketamine for treatment of chronic posttraumatic stress disorder a randomized clinical trial. Jama Psychiat. 2014;71:681\u20138.","journal-title":"Jama Psychiat"},{"key":"3538_CR36","doi-asserted-by":"publisher","first-page":"e77","DOI":"10.1017\/neu.2025.10030","volume":"37","author":"G Thuery","year":"2025","unstructured":"Thuery G, Sheridan C, Iusan P, Brar G, Ledden K, Freyne A, et al. Narrating the psychoneuroimmunomodulatory properties of serotonin 5-HT(2A) receptor psychedelics from a transdiagnostic perspective. Acta Neuropsychiatr. 2025;37:e77.","journal-title":"Acta Neuropsychiatr"},{"key":"3538_CR37","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1146\/annurev-med-053013-062946","volume":"66","author":"CG Abdallah","year":"2015","unstructured":"Abdallah CG, Sanacora G, Duman RS, Krystal JH. Ketamine and rapid-acting antidepressants: a window into a new neurobiology for mood disorder therapeutics. Annu Rev Med. 2015;66:509\u201323.","journal-title":"Annu Rev Med"},{"key":"3538_CR38","doi-asserted-by":"publisher","first-page":"3571","DOI":"10.1017\/S0033291715001506","volume":"45","author":"JW Murrough","year":"2015","unstructured":"Murrough JW, Soleimani L, DeWilde KE, Collins KA, Lapidus KA, Iacoviello BM, et al. Ketamine for rapid reduction of suicidal ideation: a randomized controlled trial. Psychol Med. 2015;45:3571\u201380.","journal-title":"Psychol Med"},{"key":"3538_CR39","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.neuroscience.2020.02.019","volume":"456","author":"S Lutzu","year":"2021","unstructured":"Lutzu S, Castillo PE. Modulation of NMDA receptors by G-protein-coupled receptors: role in synaptic transmission, plasticity and beyond. Neuroscience. 2021;456:27\u201342.","journal-title":"Neuroscience"},{"key":"3538_CR40","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.neuropharm.2013.02.010","volume":"74","author":"RA Nicoll","year":"2013","unstructured":"Nicoll RA, Roche KW. Long-term potentiation: peeling the onion. Neuropharmacology. 2013;74:18\u201322.","journal-title":"Neuropharmacology"},{"key":"3538_CR41","doi-asserted-by":"publisher","first-page":"2514","DOI":"10.1038\/s41386-018-0225-3","volume":"43","author":"RJ Valentino","year":"2018","unstructured":"Valentino RJ, Volkow ND. Untangling the complexity of opioid receptor function. Neuropsychopharmacology. 2018;43:2514\u201320.","journal-title":"Neuropsychopharmacology"},{"key":"3538_CR42","doi-asserted-by":"publisher","first-page":"3192","DOI":"10.1016\/j.neuron.2024.06.026","volume":"112","author":"M Li","year":"2024","unstructured":"Li M, Yang XK, Yang J, Li TX, Cui C, Peng X, et al. Ketamine ameliorates post-traumatic social avoidance by erasing the traumatic memory encoded in VTA-innervated BLA engram cells. Neuron. 2024;112:3192\u2013210.e3196","journal-title":"Neuron"},{"key":"3538_CR43","doi-asserted-by":"publisher","first-page":"71","DOI":"10.2174\/1570159X14666160202121111","volume":"15","author":"LR Vose","year":"2017","unstructured":"Vose LR, Stanton PK. Synaptic plasticity, metaplasticity and depression. Curr Neuropharmacol. 2017;15:71\u201386.","journal-title":"Curr Neuropharmacol"},{"key":"3538_CR44","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.pbb.2015.10.013","volume":"139","author":"CM Groeber Travis","year":"2015","unstructured":"Groeber Travis CM, Altman DE, Genovese RF. Ketamine administration diminishes operant responding but does not impair conditioned fear. Pharmacol Biochem Behav. 2015;139:84\u201391.","journal-title":"Pharmacol Biochem Behav"},{"key":"3538_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-024-02796-0","volume":"14","author":"C Jiang","year":"2024","unstructured":"Jiang C, DiLeone RJ, Pittenger C, Duman RS. The endogenous opioid system in the medial prefrontal cortex mediates ketamine\u2019s antidepressant-like actions. Transl Psychiatry. 2024;14:90.","journal-title":"Transl Psychiatry"},{"key":"3538_CR46","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/S0361-9230(01)00569-X","volume":"55","author":"CJ LaBuda","year":"2001","unstructured":"LaBuda CJ, Fuchs PN. The anxiolytic effect of acute ethanol or diazepam exposure is unaltered in mu-opioid receptor knockout mice. Brain Res Bull. 2001;55:755\u201360.","journal-title":"Brain Res Bull"},{"key":"3538_CR47","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1007\/s00213-014-3697-9","volume":"232","author":"LM Zhang","year":"2015","unstructured":"Zhang LM, Zhou WW, Ji YJ, Li Y, Zhao N, Chen HX, et al. Anxiolytic effects of ketamine in animal models of posttraumatic stress disorder. Psychopharmacology (Berl). 2015;232:663\u201372.","journal-title":"Psychopharmacology (Berl)"},{"key":"3538_CR48","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.bbr.2017.04.048","volume":"329","author":"M Morena","year":"2017","unstructured":"Morena M, Berardi A, Peloso A, Valeri D, Palmery M, Trezza V, et al. Effects of ketamine, dexmedetomidine and propofol anesthesia on emotional memory consolidation in rats: Consequences for the development of post-traumatic stress disorder. Behav Brain Res. 2017;329:215\u201320.","journal-title":"Behav Brain Res"},{"key":"3538_CR49","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-018-0310-8","volume":"8","author":"KD Radford","year":"2018","unstructured":"Radford KD, Park TY, Jaiswal S, Pan H, Knutsen A, Zhang M, et al. Enhanced fear memories and brain glucose metabolism ((18)F-FDG-PET) following sub-anesthetic intravenous ketamine infusion in Sprague-Dawley rats. Transl Psychiatry. 2018;8:263.","journal-title":"Transl Psychiatry"},{"key":"3538_CR50","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1038\/s41386-023-01606-3","volume":"48","author":"O Duek","year":"2023","unstructured":"Duek O, Korem N, Li Y, Kelmendi B, Amen S, Gordon C, et al. Long term structural and functional neural changes following a single infusion of ketamine in PTSD. Neuropsychopharmacology. 2023;48:1648\u201358.","journal-title":"Neuropsychopharmacology"},{"key":"3538_CR51","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1038\/s41386-022-01266-9","volume":"47","author":"CG Abdallah","year":"2022","unstructured":"Abdallah CG, Roache JD, Gueorguieva R, Averill LA, Young-McCaughan S, Shiroma PR, et al. Dose-related effects of ketamine for antidepressant-resistant symptoms of posttraumatic stress disorder in veterans and active duty military: a double-blind, randomized, placebo-controlled multi-center clinical trial. Neuropsychopharmacology. 2022;47:1574\u201381.","journal-title":"Neuropsychopharmacology"},{"key":"3538_CR52","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1177\/154733251903100411","volume":"31","author":"C Ross","year":"2019","unstructured":"Ross C, Jain R, Bonnett CJ, Wolfson P. High-dose ketamine infusion for the treatment of posttraumatic stress disorder in combat veterans. Ann Clin Psychiatry. 2019;31:271\u20139.","journal-title":"Ann Clin Psychiatry"},{"key":"3538_CR53","doi-asserted-by":"publisher","first-page":"107569","DOI":"10.1016\/j.cct.2024.107569","volume":"143","author":"PR Shiroma","year":"2024","unstructured":"Shiroma PR, Thuras P, Polusny MA, Kehle-Forbes S, Disner S, Pardo JV, et al. Ketamine-enhanced prolonged exposure therapy in veterans with PTSD: A randomized controlled trial protocol. Contemp Clin Trials. 2024;143:107569.","journal-title":"Contemp Clin Trials"},{"key":"3538_CR54","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1159\/000507095","volume":"89","author":"BM Keizer","year":"2020","unstructured":"Keizer BM, Roache JD, Jones JR, Kalpinski RJ, Porcerelli JH, Krystal JH. Continuous ketamine infusion for pain as an opportunity for psychotherapy for PTSD: a case series of ketamine-enhanced psychotherapy for PTSD and pain (KEP-P2). Psychother Psychosom. 2020;89:326\u20139.","journal-title":"Psychother Psychosom"},{"key":"3538_CR55","doi-asserted-by":"publisher","first-page":"803279","DOI":"10.3389\/fpsyt.2021.803279","volume":"12","author":"S Dames","year":"2021","unstructured":"Dames S, Kryskow P, Watler C. A cohort-based case report: the impact of ketamine-assisted therapy embedded in a community of practice framework for healthcare providers with PTSD and depression. Front Psychiatry. 2021;12:803279.","journal-title":"Front Psychiatry"},{"key":"3538_CR56","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.pnpbp.2014.06.013","volume":"54","author":"MH Ji","year":"2014","unstructured":"Ji MH, Jia M, Zhang MQ, Liu WX, Xie ZC, Wang ZY, et al. Dexmedetomidine alleviates anxiety-like behaviors and cognitive impairments in a rat model of post-traumatic stress disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2014;54:284\u20138.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"3538_CR57","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.jad.2024.03.137","volume":"356","author":"A Seshadri","year":"2024","unstructured":"Seshadri A, Prokop LJ, Singh B. Efficacy of intravenous ketamine and intranasal esketamine with dose escalation for major depression: A systematic review and meta-analysis. J Affect Disord. 2024;356:379\u201384.","journal-title":"J Affect Disord"},{"key":"3538_CR58","doi-asserted-by":"publisher","first-page":"865466","DOI":"10.3389\/fpsyt.2022.865466","volume":"13","author":"M Rotharmel","year":"2022","unstructured":"Rotharmel M, Benosman C, El-Hage W, Berjamin C, Ribayrol D, Guillin O, et al. Efficacy and safety of intranasal esketamine in patients with treatment-resistant depression and comorbid chronic post-traumatic stress disorder: open-label single-arm pilot study. Front Psychiatry. 2022;13:865466.","journal-title":"Front Psychiatry"},{"key":"3538_CR59","doi-asserted-by":"publisher","first-page":"101439","DOI":"10.1016\/j.eclinm.2022.101439","volume":"48","author":"H Artin","year":"2022","unstructured":"Artin H, Bentley S, Mehaffey E, Liu FX, Sojourner K, Bismark AW, et al. Effects of intranasal (S)-ketamine on veterans with co-morbid treatment-resistant depression and PTSD: A retrospective case series. EClinicalMedicine. 2022;48:101439.","journal-title":"EClinicalMedicine"},{"key":"3538_CR60","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.2147\/DDDT.S461122","volume":"18","author":"YH Cai","year":"2024","unstructured":"Cai YH, Wang CY, Fang YB, Ma HY, Gao YQ, Wang Z, et al. Preoperative anxiolytic and sedative effects of intranasal remimazolam and dexmedetomidine: a randomized controlled clinical study in children undergoing general surgeries. Drug Des Devel Ther. 2024;18:1613\u201325.","journal-title":"Drug Des Devel Ther"},{"key":"3538_CR61","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1007\/s40266-023-01027-3","volume":"40","author":"N Dieudonne Rahm","year":"2023","unstructured":"Dieudonne Rahm N, Zaccaria I, Gil Wey B, Pautex S, Habre W, Elia N. Intranasal dexmedetomidine for pain management in older patients: a cross-over, randomized, double-blinded, active-controlled trial. Drugs Aging. 2023;40:527\u201338.","journal-title":"Drugs Aging"},{"key":"3538_CR62","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s12877-024-04726-7","volume":"24","author":"W Fu","year":"2024","unstructured":"Fu W, Xu H, Zhao T, Xu J, Wang F. Effects of dexmedetomidine combined with etomidate on postoperative cognitive function in older patients undergoing total intravenous anaesthesia: a randomized, double-blind, controlled trial. BMC Geriatr. 2024;24:97.","journal-title":"BMC Geriatr"},{"key":"3538_CR63","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.neuint.2009.05.014","volume":"55","author":"K Gyires","year":"2009","unstructured":"Gyires K, Zadori ZS, Torok T, Matyus P. alpha(2)-Adrenoceptor subtypes-mediated physiological, pharmacological actions. Neurochem Int. 2009;55:447\u201353.","journal-title":"Neurochem Int"},{"key":"3538_CR64","doi-asserted-by":"publisher","first-page":"136347","DOI":"10.1016\/j.neulet.2021.136347","volume":"766","author":"X Qing","year":"2022","unstructured":"Qing X, Xu YL, Liu H, Liu XS. The influence of anesthesia and surgery on fear extinction. Neurosci Lett. 2022;766:136347.","journal-title":"Neurosci Lett"},{"key":"3538_CR65","doi-asserted-by":"publisher","first-page":"e2318611","DOI":"10.1001\/jamanetworkopen.2023.18611","volume":"6","author":"Y Yu","year":"2023","unstructured":"Yu Y, Li Y, Han D, Gong C, Wang L, Li B, et al. Effect of dexmedetomidine on posttraumatic stress disorder in patients undergoing emergency trauma surgery: a randomized clinical trial. JAMA Netw Open. 2023;6:e2318611.","journal-title":"JAMA Netw Open"},{"key":"3538_CR66","doi-asserted-by":"publisher","DOI":"10.1111\/cns.70407","volume":"31","author":"X Hao","year":"2025","unstructured":"Hao X, Zhang Z, Yang L, Guo Y, Cao F, Cao J, et al. Association of dexmedetomidine with postoperative depressive symptoms in older surgical patients: a prospective multicenter study. CNS Neurosci Ther. 2025;31:e70407.","journal-title":"CNS Neurosci Ther"},{"key":"3538_CR67","doi-asserted-by":"publisher","first-page":"1052288","DOI":"10.3389\/fnmol.2023.1052288","volume":"16","author":"J Huang","year":"2023","unstructured":"Huang J, Xu F, Yang L, Tuolihong L, Wang X, Du Z, et al. Involvement of the GABAergic system in PTSD and its therapeutic significance. Front Mol Neurosci. 2023;16:1052288.","journal-title":"Front Mol Neurosci"},{"key":"3538_CR68","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/S0006-8993(99)02151-4","volume":"852","author":"SM O\u2019Shea","year":"2000","unstructured":"O\u2019Shea SM, Wong LC, Harrison NL. Propofol increases agonist efficacy at the GABA(A) receptor. Brain Res. 2000;852:344\u20138.","journal-title":"Brain Res"},{"key":"3538_CR69","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.bja.2018.05.046","volume":"121","author":"N Samuel","year":"2018","unstructured":"Samuel N, Taub AH, Paz R, Raz A. Implicit aversive memory under anaesthesia in animal models: a narrative review. Br J Anaesth. 2018;121:219\u201332.","journal-title":"Br J Anaesth"},{"key":"3538_CR70","doi-asserted-by":"publisher","first-page":"120349","DOI":"10.1016\/j.lfs.2022.120349","volume":"293","author":"W Niu","year":"2022","unstructured":"Niu W, Duan Y, Kang Y, Cao X, Xue Q. Propofol improves learning and memory in post-traumatic stress disorder (PTSD) mice via recovering hippocampus synaptic plasticity. Life Sci. 2022;293:120349.","journal-title":"Life Sci"},{"key":"3538_CR71","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1038\/s42003-024-07105-5","volume":"7","author":"C Chen","year":"2024","unstructured":"Chen C, Li S, Zhou Y, Huang H, Lin JT, Wu WF, et al. Neuronal excitation-inhibition imbalance in the basolateral amygdala is involved in propofol-mediated enhancement of fear memory. Commun Biol. 2024;7:1408.","journal-title":"Commun Biol"},{"key":"3538_CR72","doi-asserted-by":"publisher","DOI":"10.1186\/cc11681","volume":"16","author":"M Usuki","year":"2012","unstructured":"Usuki M, Matsuoka Y, Nishi D, Yonemoto N, Matsumura K, Otomo Y, et al. Potential impact of propofol immediately after motor vehicle accident on later symptoms of posttraumatic stress disorder at 6-month follow up: a retrospective cohort study. Crit Care. 2012;16:R196.","journal-title":"Crit Care"},{"key":"3538_CR73","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.cgh.2020.09.018","volume":"19","author":"HS Lee","year":"2021","unstructured":"Lee HS, Nagra N, La Selva D, Kozarek RA, Ross A, Weigel W, et al. Nurse-administered propofol continuous infusion sedation for gastrointestinal endoscopy in patients who are difficult to sedate. Clin Gastroenterol H. 2021;19:180\u20138.","journal-title":"Clin Gastroenterol H"},{"key":"3538_CR74","doi-asserted-by":"publisher","first-page":"2638","DOI":"10.1056\/NEJMra0808281","volume":"363","author":"EN Brown","year":"2010","unstructured":"Brown EN, Lydic R, Schiff ND. General anesthesia, sleep, and coma. N Engl J Med. 2010;363:2638\u201350.","journal-title":"N Engl J Med"},{"key":"3538_CR75","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1111\/j.1460-9568.2004.03603.x","volume":"20","author":"A Ranft","year":"2004","unstructured":"Ranft A, Kurz J, Deuringer M, Haseneder R, Dodt HU, Zieglgansberger W, et al. Isoflurane modulates glutamatergic and GABAergic neurotransmission in the amygdala. Eur J Neurosci. 2004;20:1276\u201380.","journal-title":"Eur J Neurosci"},{"key":"3538_CR76","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1097\/ALN.0b013e3181974f3e","volume":"110","author":"V Rau","year":"2009","unstructured":"Rau V, Oh I, Laster M, Eger EI II, Fanselow MS. Isoflurane suppresses stress-enhanced fear learning in a rodent model of post\u2013traumatic stress disorder. Anesthesiology. 2009;110:487\u201395.","journal-title":"Anesthesiology"},{"key":"3538_CR77","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/0165-6147(91)90567-C","volume":"12","author":"I Izquierdo","year":"1991","unstructured":"Izquierdo I, Medina JH. GABAA receptor modulation of memory: the role of endogenous benzodiazepines. Trends Pharmacol Sci. 1991;12:260\u20135.","journal-title":"Trends Pharmacol Sci"},{"key":"3538_CR78","first-page":"S186","volume":"66","author":"LL McGhee","year":"2009","unstructured":"McGhee LL, Maani CV, Garza TH, DeSocio PA, Gaylord KM, Black IH. The relationship of intravenous midazolam and posttraumatic stress disorder development in burned soldiers. J Trauma. 2009;66:S186\u2013190.","journal-title":"J Trauma"},{"key":"3538_CR79","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/sj.mp.4002054","volume":"13","author":"E Geuze","year":"2008","unstructured":"Geuze E, van Berckel BN, Lammertsma AA, Boellaard R, de Kloet CS, Vermetten E, et al. Reduced GABAA benzodiazepine receptor binding in veterans with post-traumatic stress disorder. Mol Psychiatry. 2008;13:74\u201383.","journal-title":"Mol Psychiatry"},{"key":"3538_CR80","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.aucc.2021.06.004","volume":"35","author":"D Long","year":"2022","unstructured":"Long D, Gibbons K, Le Brocque R, Schults JA, Kenardy J, Dow B. Midazolam exposure in the paediatric intensive care unit predicts acute post-traumatic stress symptoms in children. Aust Crit Care. 2022;35:408\u201314.","journal-title":"Aust Crit Care"},{"key":"3538_CR81","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.ajem.2021.05.056","volume":"49","author":"C Ramdin","year":"2021","unstructured":"Ramdin C, Yu C, Colorado J, Nelson L. The impact of adherence to a guideline for minimizing opioid use for treatment of pain in an urban emergency department. Am J Emerg Med. 2021;49:104\u20139.","journal-title":"Am J Emerg Med"},{"key":"3538_CR82","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.brainresrev.2009.09.008","volume":"62","author":"AW Bruijnzeel","year":"2009","unstructured":"Bruijnzeel AW. kappa-Opioid receptor signaling and brain reward function. Brain Res Rev. 2009;62:127\u201346.","journal-title":"Brain Res Rev"},{"key":"3538_CR83","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s40122-019-00143-6","volume":"9","author":"J Gudin","year":"2020","unstructured":"Gudin J, Fudin J. A narrative pharmacological review of buprenorphine: a unique opioid for the treatment of chronic pain. Pain Ther. 2020;9:41\u201354.","journal-title":"Pain Ther"},{"key":"3538_CR84","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1124\/jpet.102.046433","volume":"305","author":"SD Mague","year":"2003","unstructured":"Mague SD, Pliakas AM, Todtenkopf MS, Tomasiewicz HC, Zhang Y, Stevens WC Jr, et al. Antidepressant-like effects of kappa-opioid receptor antagonists in the forced swim test in rats. J Pharmacol Exp Ther. 2003;305:323\u201330.","journal-title":"J Pharmacol Exp Ther"},{"key":"3538_CR85","doi-asserted-by":"publisher","first-page":"771767","DOI":"10.3389\/fnbeh.2021.771767","volume":"15","author":"RML Michalscheck","year":"2021","unstructured":"Michalscheck RML, Leidl DM, Westbrook RF, Holmes NM. The opioid receptor antagonist naloxone enhances first-order fear conditioning, second-order fear conditioning and sensory preconditioning in rats. Front Behav Neurosci. 2021;15:771767.","journal-title":"Front Behav Neurosci"},{"key":"3538_CR86","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1037\/0735-7044.118.1.111","volume":"118","author":"GP McNally","year":"2004","unstructured":"McNally GP, Pigg M, Weidemann G. Blocking, unblocking, and overexpectation of fear: a role for opioid receptors in the regulation of pavlovian association formation. Behav Neurosci. 2004;118:111\u201320.","journal-title":"Behav Neurosci"},{"key":"3538_CR87","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1111\/ajad.12860","volume":"28","author":"EP Lake","year":"2019","unstructured":"Lake EP, Mitchell BG, Shorter DI, Kosten T, Domingo CB, Walder AM. Buprenorphine for the treatment of posttraumatic stress disorder. Am J Addict. 2019;28:86\u201391.","journal-title":"Am J Addict"},{"key":"3538_CR88","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.4088\/JCP.15m09893","volume":"77","author":"KH Seal","year":"2016","unstructured":"Seal KH, Maguen S, Bertenthal D, Batki SL, Striebel J, Stein MB, et al. Observational evidence for buprenorphine\u2019s impact on posttraumatic stress symptoms in veterans with chronic pain and opioid use disorder. J Clin Psychiatry. 2016;77:1182\u20138.","journal-title":"J Clin Psychiatry"},{"key":"3538_CR89","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1001\/jama.2012.234","volume":"307","author":"KH Seal","year":"2012","unstructured":"Seal KH, Shi Y, Cohen G, Cohen BE, Maguen S, Krebs EE, et al. Association of mental health disorders with prescription opioids and high-risk opioid use in US veterans of Iraq and Afghanistan. JAMA. 2012;307:940\u20137.","journal-title":"JAMA"},{"key":"3538_CR90","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1080\/15504263.2017.1325033","volume":"13","author":"B Shiner","year":"2017","unstructured":"Shiner B, Westgate CL, Bernardy NC, Schnurr PP, Watts BV. Trends in opioid use disorder diagnoses and medication treatment among veterans with posttraumatic stress disorder. J Dual Diagn. 2017;13:201\u201312.","journal-title":"J Dual Diagn"},{"key":"3538_CR91","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2023.115462","volume":"328","author":"SK Garrey","year":"2023","unstructured":"Garrey SK, Locke S, Pollari C, Li J, Takemoto E. Post-traumatic stress disorder and risk of first-time and repeated opioid-related hospitalizations among world trade center health registry enrollees. Psychiatry Res. 2023;328:115462.","journal-title":"Psychiatry Res"},{"key":"3538_CR92","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1097\/HTR.0000000000000546","volume":"35","author":"JR Fonda","year":"2020","unstructured":"Fonda JR, Gradus JL, Brogly SB, McGlinchey RE, Milberg WP, Fredman L. Traumatic brain injury and opioid overdose among post-9\/11 veterans with long-term opioid treatment of chronic pain. J Head Trauma Rehabil. 2020;35:209\u201317.","journal-title":"J Head Trauma Rehabil"},{"key":"3538_CR93","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1037\/pha0000661","volume":"31","author":"BM Fogle","year":"2023","unstructured":"Fogle BM, Kabel K, Shepherd JM, Rogers AH, Vujanovic AA, Zvolensky MJ. Posttraumatic stress and distress tolerance in relation to opioid misuse and dependence among trauma-exposed adults with chronic pain. Exp Clin Psychopharmacol. 2023;31:953\u201362.","journal-title":"Exp Clin Psychopharmacol"},{"key":"3538_CR94","doi-asserted-by":"publisher","first-page":"636","DOI":"10.2174\/1570159X22666231027111147","volume":"22","author":"TG Zaretsky","year":"2024","unstructured":"Zaretsky TG, Jagodnik KM, Barsic R, Antonio JH, Bonanno PA, MacLeod C, et al. The psychedelic future of post-traumatic stress disorder treatment. Curr Neuropharmacol. 2024;22:636\u2013735.","journal-title":"Curr Neuropharmacol"},{"key":"3538_CR95","doi-asserted-by":"publisher","first-page":"e2449026","DOI":"10.1001\/jamanetworkopen.2024.49026","volume":"7","author":"AL Back","year":"2024","unstructured":"Back AL, Freeman-Young TK, Morgan L, Sethi T, Baker KK, Myers S, et al. Psilocybin therapy for clinicians with symptoms of depression from frontline care during the COVID-19 pandemic: a randomized clinical trial. JAMA Netw Open. 2024;7:e2449026.","journal-title":"JAMA Netw Open"},{"key":"3538_CR96","doi-asserted-by":"publisher","first-page":"e0313741","DOI":"10.1371\/journal.pone.0313741","volume":"20","author":"S Meshkat","year":"2025","unstructured":"Meshkat S, J Zeifman R, Stewart K, Janssen-Aguilar R, Lou W, Jetly R, et al. Psilocybin-assisted massed cognitive processing therapy for chronic posttraumatic stress disorder: Protocol for an open-label pilot feasibility trial. PLoS ONE. 2025;20:e0313741.","journal-title":"PLoS ONE"},{"key":"3538_CR97","first-page":"299","volume":"326","author":"A Slomski","year":"2021","unstructured":"Slomski A. MDMA-assisted therapy highly effective for PTSD. JAMA. 2021;326:299.","journal-title":"JAMA"},{"key":"3538_CR98","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1038\/s41591-021-01336-3","volume":"27","author":"JM Mitchell","year":"2021","unstructured":"Mitchell JM, Bogenschutz M, Lilienstein A, Harrison C, Kleiman S, Parker-Guilbert K, et al. MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study. Nat Med. 2021;27:1025\u201333.","journal-title":"Nat Med"},{"key":"3538_CR99","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1213\/ANE.0b013e31824590a5","volume":"116","author":"A Turan","year":"2013","unstructured":"Turan A, Mascha EJ, You J, Kurz A, Shiba A, Saager L, et al. The association between nitrous oxide and postoperative mortality and morbidity after noncardiac surgery. Anesth Analg. 2013;116:1026\u201333.","journal-title":"Anesth Analg"},{"key":"3538_CR100","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1002\/cpt.557","volume":"101","author":"DE Nichols","year":"2017","unstructured":"Nichols DE, Johnson MW, Nichols CD. Psychedelics as medicines: an emerging new paradigm. Clin Pharmacol Ther. 2017;101:209\u201319.","journal-title":"Clin Pharmacol Ther"},{"key":"3538_CR101","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1176\/appi.ajp.2019.19010035","volume":"177","author":"CM Reiff","year":"2020","unstructured":"Reiff CM, Richman EE, Nemeroff CB, Carpenter LL, Widge AS, Rodriguez CI, et al. Psychedelics and psychedelic-assisted psychotherapy. Am J Psychiat. 2020;177:391\u2013410.","journal-title":"Am J Psychiat"},{"key":"3538_CR102","doi-asserted-by":"publisher","first-page":"856","DOI":"10.3390\/brainsci11070856","volume":"11","author":"G Martinotti","year":"2021","unstructured":"Martinotti G, Chiappini S, Pettorruso M, Mosca A, Miuli A, Di Carlo F, et al. Therapeutic potentials of ketamine and esketamine in obsessive-compulsive disorder (OCD), substance use disorders (SUD) and eating disorders (ED): a review of the current literature. Brain Sci. 2021;11:856.","journal-title":"Brain Sci"},{"key":"3538_CR103","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1097\/ACO.0000000000001176","volume":"35","author":"KM Vogt","year":"2022","unstructured":"Vogt KM, Pryor KO. Anesthesia and the neurobiology of fear and posttraumatic stress disorder. Curr Opin Anaesthesiol. 2022;35:593\u20139.","journal-title":"Curr Opin Anaesthesiol"},{"key":"3538_CR104","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1176\/appi.ajp.2020.20050596","volume":"178","author":"A Feder","year":"2021","unstructured":"Feder A, Costi S, Rutter SB, Collins AB, Govindarajulu U, Jha MK, et al. A randomized controlled trial of repeated ketamine administration for chronic posttraumatic stress disorder. Am J Psychiatry. 2021;178:193\u2013202.","journal-title":"Am J Psychiatry"},{"key":"3538_CR105","doi-asserted-by":"publisher","first-page":"247054702098167","DOI":"10.1177\/2470547020981670","volume":"4","author":"AR Dadabayev","year":"2020","unstructured":"Dadabayev AR, Joshi SA, Reda MH, Lake T, Hausman MS, Domino E, et al. Low dose ketamine infusion for comorbid posttraumatic stress disorder and chronic pain: a randomized double-blind clinical trial. Chronic Stress (Thousand Oaks). 2020;4:2470547020981670.","journal-title":"Chronic Stress (Thousand Oaks)"}],"container-title":["Molecular Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41380-026-03538-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41380-026-03538-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41380-026-03538-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T18:01:35Z","timestamp":1783965695000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41380-026-03538-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,24]]},"references-count":105,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["3538"],"URL":"https:\/\/doi.org\/10.1038\/s41380-026-03538-y","relation":{},"ISSN":["1359-4184","1476-5578"],"issn-type":[{"value":"1359-4184","type":"print"},{"value":"1476-5578","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,24]]},"assertion":[{"value":"24 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}